72 related articles for article (PubMed ID: 11848539)
1. Dysregulative lymphoma theory revisited; what can we learn from cytokines, CD classes and genes?
Krueger GR; Nguyen AN; Uthman M; Brandt ME; Buja LM
Anticancer Res; 2001; 21(5):3653-61. PubMed ID: 11848539
[TBL] [Abstract][Full Text] [Related]
2. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cells and immune microenvironment in malignant lymphoma.
de Jong D; Enblad G
J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
[TBL] [Abstract][Full Text] [Related]
4. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
5. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
[TBL] [Abstract][Full Text] [Related]
6. [Classification and differential diagnosis of NK/T-cell lymphomas].
Feller AC
Verh Dtsch Ges Pathol; 2003; 87():43-52. PubMed ID: 16888893
[TBL] [Abstract][Full Text] [Related]
7. [Classification of lymphomas].
Molina T; Diebold J; Audouin J
Rev Prat; 2002 May; 52(9):951-8. PubMed ID: 12063760
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms].
Yin HF; Li T; Li JX
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1556-60. PubMed ID: 14642107
[TBL] [Abstract][Full Text] [Related]
9. DCs in lymphoma--biology and therapeutic aspects.
Schultze JL; Fiore F; von Bergwelt-Baildon M
Cytotherapy; 2004; 6(2):138-47. PubMed ID: 15203990
[No Abstract] [Full Text] [Related]
10. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
11. Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.
Mi JQ; Manches O; Wang J; Perron P; Weisbuch S; Marche PN; Renversez JC; Bensa JC; Sotto JJ; Cahn JY; Leroux D; Bonnefoix T
Br J Haematol; 2006 Nov; 135(3):324-35. PubMed ID: 16984392
[TBL] [Abstract][Full Text] [Related]
12. Host immune response in B-cell lymphomas: friend or foe?
Juszczyński P; Nowak J; Warzocha K
Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
[TBL] [Abstract][Full Text] [Related]
13. [The WHO (1997) classification of 370 cases of malignant lymphomas].
He S; Zhang JB; Zhang JG; Yang SY; Han F
Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):519-22. PubMed ID: 14690580
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
15. t(8;13)-positive bilineal lymphomas: report of 6 cases.
Vega F; Medeiros LJ; Davuluri R; Cromwell CC; Alkan S; Abruzzo LV
Am J Surg Pathol; 2008 Jan; 32(1):14-20. PubMed ID: 18162765
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
17. Animal models of intraocular lymphomas.
Touitou V; Bodaghi B; de Kozak Y; Lehoang P; Sautès-Fridman C; Fisson S
Ophthalmic Res; 2008; 40(3-4):208-11. PubMed ID: 18421241
[TBL] [Abstract][Full Text] [Related]
18. TCM-1: a nonlinear dynamical computational model to simulate cellular changes in the T cell system; conceptional design and validation.
Krueger GR; Brandt ME; Wang G; Buja LM
Anticancer Res; 2003; 23(1A):123-35. PubMed ID: 12680203
[TBL] [Abstract][Full Text] [Related]
19. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
20. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
